Publications by authors named "Cem Akin"

Claim this Profile
I
Idiopathic Anaphylaxis.
Moshe Ben-Shoshan, Akin Cem, Victoria E Cook, Roy Khalaf, George Freigeh

J Allergy Clin Immunol Pract· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic haematopoietic cell transplantation in advanced systemic mastocytosis in the new era: A CIBMTR study.
Celalettin Ustun, Mei-Jie Zhang, Andrew Peterson, Alexander Baek, Mounzer Agha, Cem Akin

Br J Haematol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autonomic function testing and symptom severity in patients with suspected mast cell activation disorders.
Amro M Stino, Jodi Nelson, Olivia Gutgsell, Ahmed Eldokla, Jasmine Liu, Cem Akin

Auton Neurosci· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The state of the academic medical center in allergy/immunology: Work Group Report of the AAAAI A/I Division Directors Committee.
Carla M Davis, Cem Akin, Sami L Bahna, Karen S Hsu Blatman, Tara Carr

J Allergy Clin Immunol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosis and Management of Patients With Mast Cell Activation Syndromes: Status 2026.
Cem Akin, Theo Gülen, Mariana C Castells, Hanneke Oude Elberink, Peter Valent

J Allergy Clin Immunol Pract· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of indolent mastocytosis and mast cell activation syndrome: A clinical yardstick.
Cem Akin, Joseph H Butterfield, Mariana Castells, Jonathan J Lyons

Ann Allergy Asthma Immunol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of KIT D816V in anaphylaxis or systemic mast cell activation.
Karin Hartmann, Ivan Alvarez-Twose, Jonathan A Bernstein, Cem Akin, Bethan Myers

J Allergy Clin Immunol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolution of mast cell research associated with the Laboratory of Allergic Diseases, 1985-2022: Summary of the 2023 NIAID Symposium.
Hirsh D Komarow, Gunnar Nilsson, Yoshimichi Okayama, Yoseph Mekori, Ana Olivera, Cem Akin

J Allergy Clin Immunol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Continued symptom and quality of life improvement with favorable safety shown with long-term avapritinib in indolent systemic mastocytosis.
Mariana Castells, Cem Akin, Karin Hartmann, Sigurd Broesby-Olsen, Tracy I George

J Allergy Clin Immunol Pract· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How we treat mast cell activation syndrome.
Theo Gülen, Cem Akin

Ann Allergy Asthma Immunol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic mastocytosis: current status and challenges in 2024.
Celalettin Ustun, Fatma Keklik Karadag, Michael A Linden, Peter Valent, Cem Akin

Blood Adv· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrating a Rare Disease into Practice: Development of a Toolkit for Systemic Mastocytosis.
Sandra Kurtin, Cem Akin, Tracey I George, Edward Pearson

J Adv Pract Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mastocytosis.
Cem Akin, Michel Arock, Melody C Carter, Tracy I George, Peter Valent

Nat Rev Dis Primers· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Mastocytosis Control Test: A Patient-Reported Outcome Measure Assessing Disease Control.
Frank Siebenhaar, Senan Sofi, Sophia Neisinger, Cem Akin, Polina Pyatilova

J Allergy Clin Immunol Pract· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Demographics, Types of Patient-Reported Allergic Diseases, and Anaphylaxis in Mastocytosis: A Single-Center US Experience.
Rayan N Kaakati, Dilawar Khokhar, Cem Akin

J Allergy Clin Immunol Pract· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current status and future directions in food protein-induced enterocolitis syndrome: An NIAID workshop report of the June 22, 2022, virtual meeting.
Anna Nowak-Wegrzyn, Scott H Sicherer, Cem Akin, Sara Anvari, Lisa M Bartnikas

J Allergy Clin Immunol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Omalizumab for mast cell disorders.
Cem Akin

J Allergy Clin Immunol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Harmonization of Diagnostic Criteria in Mastocytosis for Use in Clinical Practice: WHO vs ICC vs AIM/ECNM.
Peter Valent, Karin Hartmann, Gregor Hoermann, Andreas Reiter, Iván Alvarez-Twose, Cem Akin

J Allergy Clin Immunol Pract· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mast cell activation syndrome: Current understanding and research needs.
Mariana Castells, Matthew P Giannetti, Matthew J Hamilton, Peter Novak, Olga Pozdnyakova, Cem Akin

J Allergy Clin Immunol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detecting Changes in Mast Cell Numbers Versus Activation in Human Disease: A Roadblock for Current Biomarkers?
Cem Akin, Frank Siebenhaar, Joshua B Wechsler, Bradford A Youngblood, Marcus Maurer

J Allergy Clin Immunol Pract· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reversible Elevation of Tryptase Over the Individual's Baseline: Why is It the Best Biomarker for Severe Systemic Mast Cell Activation and MCAS?
Peter Valent, Cem Akin, Michel Arock

Curr Allergy Asthma Rep· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dilemma of Mast Cell Activation Syndrome: Overdiagnosed or Underdiagnosed?
Cem Akin

J Allergy Clin Immunol Pract· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anaphylaxis: A 2023 practice parameter update.
David B K Golden, Julie Wang, Susan Waserman, Cem Akin, Ronna L Campbell, Cem Akin

Ann Allergy Asthma Immunol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody-Based and Cell Therapies for Advanced Mastocytosis: Established and Novel Concepts.
Peter Valent, Cem Akin, Michel Arock, Karoline V Gleixner, Hildegard Greinix

Int J Mol Sci· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Avapritinib versus Placebo in Indolent Systemic Mastocytosis.
Jason Gotlib, Mariana Castells, Hanneke Oude Elberink, Frank Siebenhaar, Karin Hartmann, Cem Akin

NEJM Evid· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis